background
wu
ki
polyomavirus
discov
sampl
respiratori
secret
children
acut
respiratori
symptom
seroepidemiolog
studi
shown
virus
wide
distribut
throughout
world
incid
spain
determin
transplant
patient
earli
detect
treatment
viral
infect
may
influenc
prognosi
surviv
associ
increas
morbid
mortal
includ
graft
failur
method
aim
determin
preval
clinic
characterist
wu
ki
polyomavirus
among
patient
undergo
hematolog
solid
organ
transplant
hospit
de
valdecilla
santand
spain
inhous
polymeras
chain
reaction
use
specif
primer
carri
invas
lower
respiratori
sampl
hospit
patient
suspect
respiratori
infect
andor
graft
dysfunct
compar
asymptomat
transplant
patient
result
overal
obtain
kiposit
sampl
wuposit
sampl
higher
preval
wu
ki
polyomavirus
symptomat
popul
compar
control
group
although
data
suggest
detect
respiratori
sampl
sporad
often
associ
microorgan
pay
special
attent
associ
case
graft
failur
studi
need
larger
number
sampl
explor
potenti
clinic
impact
emerg
polyomavirus
transplant
recipi
n
new
human
polyomavirus
wu
ki
kipyv
wupyv
identifi
respiratori
sampl
patient
respiratori
ill
kipyv
wupyv
belong
genera
polyomavirida
famili
along
recent
uncov
human
polyomavirus
small
nonenvelop
dna
virus
icosahedr
capsid
contain
circular
doublestrand
dna
genom
kbp
length
virus
differ
substanti
shown
percentag
amino
acid
ident
phylogenet
analysi
wupyv
share
ident
kipyv
lower
similar
jcpyv
bkpyv
crossreact
report
among
viral
capsid
protein
kipyv
wupyv
determin
competit
assay
seroepidemiolog
survey
determin
primari
infect
kipyv
wupyv
occur
childhood
shown
studi
probabl
respiratori
oralfec
rout
remain
latent
get
reactiv
presenc
immunosuppress
nguyen
et
al
report
seroposit
wupyv
kipyv
age
group
year
use
enzymelink
immunosorb
assay
recombin
capsid
protein
kipyv
correl
aidsrel
immunosuppress
reactiv
kipyv
wupyv
lymphoid
tissu
although
clinic
consequ
examin
mourez
et
al
found
higher
preval
kipyv
infect
among
hematopoiet
stem
cell
transplant
patient
suggest
profound
tcell
defici
could
factor
facilit
kipyv
replic
spain
data
avail
comprehens
describ
incid
associ
detect
kipyv
wupyv
respiratori
specimen
transplant
recipi
purpos
present
studi
develop
prospect
studi
determin
preval
kipyv
wupyv
invas
lower
respiratori
tract
sampl
obtain
patient
undergon
hematolog
solid
organ
transplant
hospit
de
valdecilla
santand
spain
studi
approv
cantabria
ethic
committe
clinic
investig
juli
januari
sampl
lower
respiratori
tract
tracheal
aspir
bronchoalveolar
lavag
bronchoaspir
pleural
fluid
lung
biopsi
obtain
consecut
patient
admit
hospit
suspect
respiratori
infect
andor
graft
dysfunct
transplant
distribut
follow
lung
stem
cell
heart
liver
pancreaskidney
mean
age
year
rang
male
predomin
diagnos
respiratori
infectionpneumonia
graft
reject
respiratori
dysfunct
posttransplant
control
subject
sampl
investig
routin
bacteria
respiratori
virus
includ
human
adenoviru
influenza
b
virus
human
parainfluenza
virus
human
rhinoviru
ab
c
human
respiratori
syncyti
virus
b
human
bocavirus
human
coronavirus
human
metapneumoviru
human
enteroviru
human
cytomegaloviru
separ
aliquot
store
c
use
viral
nucleic
acid
extract
use
maxwel
autom
nucleic
acid
extractor
maxwel
viral
total
nucleic
acid
purif
kit
promega
madison
wisconsin
sampl
screen
kipyv
wupyv
carri
polymeras
chain
reaction
pcr
reaction
use
specif
primer
target
gene
respect
primer
design
sequenc
deposit
nation
center
biotechnolog
inform
wwwncbi
nlmnihgov
use
program
output
kipyv
forward
primer
revers
primer
produc
amplicon
correspond
nt
gene
wupyv
forward
primer
revers
primer
produc
amplicon
correspond
nt
gene
reaction
perform
c
minut
cycl
second
c
c
second
c
minut
final
c
minut
posit
result
confirm
sequenc
align
blastn
sequenc
avail
genbank
databas
tabl
list
characterist
patient
infect
kipyv
wupyv
posit
patient
sampl
differ
result
overal
obtain
kipyvposit
sampl
wupyvposit
sampl
group
case
wupyv
detect
symptomat
popul
wherea
kipyv
detect
versu
symptomat
control
popul
respect
mean
age
patient
infect
kipyv
wupyv
year
rang
year
differ
significantli
patient
infect
microorgan
patient
male
higher
preval
observ
recipi
hematopoiet
stem
cell
lung
transplant
patient
mean
day
transplant
rang
day
kipyv
wupyv
sole
microorgan
isol
episod
wherea
case
detect
along
anoth
microorgan
haemophilu
influenza
aspergillu
fumigatu
pseudomona
aeruginosa
patient
lung
dysfunct
due
graftversushost
diseas
kipyv
sole
pathogen
detect
respiratori
sampl
conduct
prospect
studi
wupyv
kipyv
detect
invas
respiratori
sampl
patient
transplant
frequenc
similar
describ
author
higher
preval
symptomat
wupyv
kipyv
infect
found
symptomat
popul
control
group
although
data
suggest
detect
respiratori
sampl
sporad
often
associ
microorgan
pay
special
attent
associ
case
graft
failur
patient
infect
wupyv
kipyv
vari
degre
immunosuppress
appear
differ
stage
posttransplant
period
suggest
sever
immun
compromis
necessarili
risk
factor
infect
reactiv
although
pathogen
role
wupyv
kipyv
immunocompromis
patient
unclear
sometim
sole
virus
detect
suggest
could
respiratori
pathogen
might
also
taken
account
case
acut
reject
episod
describ
elsewher
studi
need
larger
number
sampl
explor
potenti
clinic
impact
emerg
polyomavirus
transplant
recipi
